Tybourne Capital Management 13F holdings, Q3 2021
Holdings as of September 30, 2021 · filings on SEC EDGAR · latest filing →
Tybourne Capital Management disclosed 24 US equity positions worth $4.0bn in its Q3 2021 13F filing. The largest position was SE at 9.8% of the reported book, followed by MELI and PDD. Against the Q2 2021 filing, it opened 2 new positions, added to 5 and reduced 8 among the top 24 holdings.
What did Tybourne Capital Management own in Q3 2021? Top 24 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2021 |
|---|---|---|---|---|---|---|---|
| 1 | SE SEA LTD-ADR (SE US) | Consumer Cyclical | 9.8% | $390.3m | 1,224,525 | -12% | reduced |
| 2 | MELI MERCADOLIBRE INC (MELI US) | Consumer Cyclical | 8.8% | $348.8m | 207,679 | -12% | reduced |
| 3 | PDD PINDUODUO INC-ADR (PDD US) | Consumer Cyclical | 8.0% | $317.3m | 3,499,244 | 90% | added |
| 4 | BEKE KE HOLDINGS INC (BEKE US) | Real Estate | 7.5% | $299.0m | 16,377,113 | 77% | added |
| 5 | SNOW SNOWFLAKE INC-CLASS A (SNOW US) | Technology | 7.3% | $290.2m | 959,700 | – | new |
| 6 | MDB MONGODB INC (MDB US) | Technology | 6.9% | $275.6m | 584,539 | -6% | reduced |
| 7 | V VISA INC-CLASS A SHARES (V US) | Financial Services | 6.2% | $246.6m | 1,106,942 | 0% | held |
| 8 | XYZ SQUARE INC - A (SQ US) | Technology | 5.7% | $225.8m | 941,448 | 65% | added |
| 9 | COUPA SOFTWARE INC (COUP US) | 5.5% | $219.9m | 1,003,150 | 30% | added | |
| 10 | AMZN AMAZON.COM INC (AMZN US) | Consumer Cyclical | 5.5% | $217.2m | 66,118 | -33% | reduced |
| 11 | TEAM ATLASSIAN CORP PLC-CLASS A (TEAM US) | Technology | 5.1% | $202.4m | 517,180 | -12% | reduced |
| 12 | STNE STONECO LTD-A (STNE US) | Technology | 5.0% | $200.2m | 5,766,393 | 47% | added |
| 13 | SHOP SHOPIFY INC - CLASS A (SHOP US) | Technology | 4.8% | $189.9m | 140,100 | -32% | reduced |
| 14 | ZNTL ZENTALIS PHARMACEUTICALS INC (ZNTL US) | Healthcare | 4.5% | $177.6m | 2,664,409 | 0% | held |
| 15 | TWLO TWILIO INC - A (TWLO US) | Technology | 3.9% | $153.1m | 480,000 | -29% | reduced |
| 16 | BCYC BICYCLE THERAPEUTICS LTD-ADR (BCYC US) | Healthcare | 2.1% | $81.4m | 1,957,961 | 0% | held |
| 17 | TPG PACE BENEFICIAL FIN-CL A (TPGY US) | 1.3% | $52.3m | 4,957,302 | 0% | held | |
| 18 | INHIBRX INC (INBX US) | 0.9% | $34.3m | 1,028,303 | -7% | reduced | |
| 19 | ARYA SCIENCES ACQUISITION-A (ARYD US) | 0.3% | $10.1m | 1,000,000 | 0% | held | |
| 20 | TSHA TAYSHA GENE THERAPIES INC (TSHA US) | Healthcare | 0.2% | $9.3m | 500,000 | 0% | held |
| 21 | XCUR EXICURE INC (XCUR US) | 0.2% | $8.8m | 7,325,000 | -0% | held | |
| 22 | MELI KASZEK PIONEER CORP-A (MEKA US) | 0.2% | $7.7m | 700,000 | – | new | |
| 23 | RENEO PHARMACEUTICALS INC (RPHM US) | 0.1% | $5.6m | 750,000 | 0% | held | |
| 24 | CLOOPEN GROUP HOLDING LTD (RAAS US) | 0.1% | $5.4m | 1,223,835 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.